The Regulation was evaluated in 2016 as part of the Commission's regulatory fitness and performance programme (REFIT) including on the scope of countries and diseases and general criteria for the implementation of Article 3.
Uredba je 2016. ocijenjena u okviru Komisijina programa za primjerenost i učinkovitost propisa (REFIT), uključujući u pogledu opsega zemalja i bolesti te opće kriterije za provedbu članka 3.